Peripartum cardiomyopathy: Causes, diagnosis, and treatment.
Peripartum cardiomyopathy is a life-threatening condition of unknown cause that occurs in previously healthy women during the peripartum period. It is characterized by left ventricular dysfunction and symptoms of heart failure that can arise in the last trimester of pregnancy or up to 5 months after delivery. We review its possible causes and how to recognize and manage it.
Department of Internal Medicine, University of Arizona College of Medicine, Tucson, 85724, USA. drkutty2@gmail.com.
Radhakrishnan
R
Ramaraj
Vincent L
VL
Sorrell
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D009202:Cardiomyopathies / Q000175:diagnosis / Q000208:ethnology / Q000209:etiology / Q000517:prevention & control; D000075202:Contraindications; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D016027:Heart Transplantation; D006801:Humans; D049590:Postpartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000208:ethnology / Q000209:etiology / Q000517:prevention & control; D012008:Recurrence; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin
D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D014859:Warfarin